Skip to Main Content

Paper Details

Nonmyeloablative Haploidentical Bone Marrow Transplantation with Post-Transplantation Cyclophosphamide for Pediatric and Young Adult Patients with High-Risk Hematologic Malignancies.
Biol Blood Marrow Transplant
53
2017
Cyclophosphamide, GVHD, Hematologic Malignancies, High, Patients, TRM, acute graft-versus-host disease, chronic GVHD, comorbidities, cyclophosphamide, fludarabine, hematologic malignancies, mycophenolate mofetil, neutrophils, organ dysfunction, patients, platelets, tacrolimus
Author NameAffiliation
David M LoebSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Elias T ZambidisSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Richard J JonesSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
Richard J JonesSidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital
  • 1 - 4

Datasets

Release 1.2